eHealth Initiatives Across Emerging Markets in APAC

 

LONDONDec. 31, 2014 -- The study covers the eHealth initiatives across the emerging markets in Asia-Pacific. Government initiatives and incentives that encourage technology adoption in healthcare are key drivers for private sector investment in the Asia-Pacific eHealth industry. However, inadequate infrastructure and regulatory framework development have adversely affected market growth. The current report highlights key government projects across emerging APAC countries to support healthcare digitization.

Methodology

-The purpose of this research was to conduct a qualitative evaluation of healthcare information technology (IT) policies, initiatives and regulations across emerging markets in Asia-Pacific (APAC).-Opinions presented in this research are based on in-depth interviews conducted with key opinion leaders (KOLs) such as representative of health ministries and standards organizations across each country in scope.-Additionally, secondary sources such as Frost & Sullivan content, ministry of health websites and public databases were used for further inputs.

Key Questions This Study Will Answer

How is the healthcare system structured across the scoped countries?

What are the emerging trends in eHealth and EHR coverage across countries? How does regional integration impact eHealth and EHR?

What are the current trends in adoption of healthcare IT standards? What standards are currently in use? What are the drivers and restraints in adoption of healthcare IT standards?

What is the role of the government in establishing standards? What standards are preferred by vendors and others involved in the healthcare ecosystem?

Download the full report: https://www.reportbuyer.com/product/2515979/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information: 
Sarah Smith 
Research Advisor at Reportbuyer.com 
Email: query@reportbuyer.com 
Tel: +44 208 816 85 48 
Website: www.reportbuyer.com

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.